Remove 2019 Remove Chronic Condition Remove Finance Remove Supply Chain
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Increase Transparency and Strengthen Supply Chain and Research Capacity. Part D currently has no such cap.